|
|
|
Saturday, Apr.27, 2024
|
|
|
|
|
|
miRNA: |
hsa-miR-210 |
Disease: |
diffuse large B-cell lymphoma (DLBCL) |
Relationship type: |
Unspecified |
Detection method for miRNA expression: |
microarray |
Expression pattern of miRNA: |
up-regulated |
Validated targets of miRNA from the reference: |
unknown |
Validated targets of miRNA from TarBase: |
unknown : More... |
Predicted targets: |
MIRANDA, TARGETSCAN, PICTAR-VERT |
Description: Four hsa-miR-As (miR-210, hsa-miR-155, hsa-miR-106a, hsa-miR-17-5p) were expressed at a significantly higher level in DLBCL than in normal tissue. In contrast, the remaining 11 miRNAs (hsa-miR-150, hsa-miR-145, hsa-miR-328, hsa-miR-139, hsa-miR-99a, hsa-miR-10a, hsa-miR-95, hsa-miR-149, hsa-miR-320, hsa-miR-151,let-7e) were expressed at a significantly lower level in DLBCL.A classification tree was
computed using four miRNAs (miR-330, miR-17-5p, miR-106a and miR-210) to correctly identify 98% of all 111 cases that were analysed in this study. |
Reference:
MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. | PMID:18537969
Roehle A, Hoefig KP, Repsilber D, Thorns C, Ziepert M, Wesche KO, Thiere M, Loeffler M, Klapper W, Pfreundschuh M, Matolcsy A, Bernd HW, Reiniger L, Merz H, Feller AC.
Br J Haematol. 2008 Jun 3. [Epub ahead of print] |
|
|
|
|
|
|